Search research articles
Contact Us
Filters
Showing results (221-230 of 268) with videos related to
Page
of 27
Sort By:
Journal of Viral Hepatitis
|
March 22, 2021
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study
Mina S Farag, Scott Fung, Edward Tam, et al.
BMC Infectious Diseases
|
February 27, 2010
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries
Janet M Raboud, Mona R Loutfy, DeSheng Su, et al.
Frontiers in Public Health
|
May 24, 2024
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
World Journal of Gastroenterology
|
September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue
Alnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Dermatology and Therapy
|
July 6, 2023
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
Kim A Papp, Jennifer Beecker, Curtis Cooper, et al.
Dermatology and Therapy
|
April 21, 2022
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
Kim A Papp, Jennifer Beecker, Curtis Cooper, et al.
Vaccine
|
February 14, 2012
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age
Scott A Halperin, Brian Ward, Curtis Cooper, et al.
Gastro Hep Advances
|
August 12, 2024
Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America
Hin Hin Ko, Nishi H Patel, Sarah Haylock-Jacobs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 13, 2014
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4
Gregory Everson, Curtis Cooper, Christophe Hézode, et al.
Vaccine
|
September 3, 2024
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines
Brenda L Coleman, Iris Gutmanis, Susan J Bondy, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 268) with videos related to
Sort By:
Page
of 27
Journal of Viral Hepatitis
|
March 22, 2021
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study
Mina S Farag, Scott Fung, Edward Tam, et al.
BMC Infectious Diseases
|
February 27, 2010
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries
Janet M Raboud, Mona R Loutfy, DeSheng Su, et al.
Frontiers in Public Health
|
May 24, 2024
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
World Journal of Gastroenterology
|
September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue
Alnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Dermatology and Therapy
|
July 6, 2023
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
Kim A Papp, Jennifer Beecker, Curtis Cooper, et al.
Dermatology and Therapy
|
April 21, 2022
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
Kim A Papp, Jennifer Beecker, Curtis Cooper, et al.
Vaccine
|
February 14, 2012
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age
Scott A Halperin, Brian Ward, Curtis Cooper, et al.
Gastro Hep Advances
|
August 12, 2024
Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America
Hin Hin Ko, Nishi H Patel, Sarah Haylock-Jacobs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 13, 2014
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4
Gregory Everson, Curtis Cooper, Christophe Hézode, et al.
Vaccine
|
September 3, 2024
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines
Brenda L Coleman, Iris Gutmanis, Susan J Bondy, et al.
Page
of 27